MyFinsight

HomeBlogAboutContact

MyFinsight

Making company financials insightful for everyone

Quick Links

  • About
  • Blog
  • Contact

Follow Us

  • X.com
  • Thread
  • Instagram

© 2026 MyFinsight. All rights reserved.

DownloadDownload image
Proceeds from exercise ofstock options$300K Net cash provided byfinancing activities$298K Effect of exchangerates on cash, cash...$9K Canceled cashflow$2K Net decrease incash, cash...-$34,440K Canceled cashflow$307K Stock-based compensationexpense$13,273K Accounts receivable, net-$6,826K Depreciation andamortization$6,194K Accrued expenses$1,509K Accounts payable$1,472K Other liabilities$1,316K Other non-currentassets-$225K Proceeds from maturity ofinvestments$20,550K Repurchases of common stockfor income tax...$2K Net cash used inoperating activities-$24,814K Net cash used ininvesting activities-$9,933K Canceled cashflow$30,815K Canceled cashflow$20,550K Net loss-$30,507K Purchases of investments$20,509K Accrued compensation-$12,436K Prepaid expenses andother current assets$7,735K Inventories$4,615K Other non-cashadjustments$336K Purchases of property andequipment$9,974K
Cash Flow
source: myfinsight.com

Twist Bioscience Corp (TWST)

Twist Bioscience Corp (TWST)